BR112019023962A8 - Formulação à base de vitamina e ou um éster da mesma para tratamento de biofilmes bacterianos e fúngicos - Google Patents
Formulação à base de vitamina e ou um éster da mesma para tratamento de biofilmes bacterianos e fúngicosInfo
- Publication number
- BR112019023962A8 BR112019023962A8 BR112019023962A BR112019023962A BR112019023962A8 BR 112019023962 A8 BR112019023962 A8 BR 112019023962A8 BR 112019023962 A BR112019023962 A BR 112019023962A BR 112019023962 A BR112019023962 A BR 112019023962A BR 112019023962 A8 BR112019023962 A8 BR 112019023962A8
- Authority
- BR
- Brazil
- Prior art keywords
- ester
- vitamin
- bacterial
- treatment
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Medicinal Preparation (AREA)
Abstract
Formulação para uso tópico à base de vitamina E ou um éster da mesma para remoção, redução ou inibição de um biofilme bacteriano e/ou fúngico, em que o referido éster da vitamina E é um éster com um ácido carboxílico da fórmula R-COOH, no qual R é um radical alquila com 1 a 19 átomos de carbono ou uma alquenila ou alcinila com 2 a 19 átomos de carbono.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102017000058311A IT201700058311A1 (it) | 2017-05-29 | 2017-05-29 | Formulazione a base di vitamina E o di un suo estere per il trattamento di biofilm batterici e fungini |
| PCT/EP2018/063926 WO2018219862A1 (en) | 2017-05-29 | 2018-05-28 | Formulation based on vitamin e or an ester thereof for treating bacterial and fungal biofilms |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR112019023962A2 BR112019023962A2 (pt) | 2020-06-09 |
| BR112019023962A8 true BR112019023962A8 (pt) | 2022-07-05 |
Family
ID=60294053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019023962A BR112019023962A8 (pt) | 2017-05-29 | 2018-05-28 | Formulação à base de vitamina e ou um éster da mesma para tratamento de biofilmes bacterianos e fúngicos |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US20200360339A1 (pt) |
| EP (1) | EP3630092B1 (pt) |
| CN (1) | CN110650737A (pt) |
| AU (1) | AU2018275487B2 (pt) |
| BR (1) | BR112019023962A8 (pt) |
| CA (1) | CA3061568C (pt) |
| CL (1) | CL2019003254A1 (pt) |
| DK (1) | DK3630092T3 (pt) |
| EA (1) | EA201992190A1 (pt) |
| ES (1) | ES2919423T3 (pt) |
| GE (1) | GEP20207179B (pt) |
| HR (1) | HRP20220808T1 (pt) |
| HU (1) | HUE059185T2 (pt) |
| IT (1) | IT201700058311A1 (pt) |
| LT (1) | LT3630092T (pt) |
| MA (1) | MA48936B1 (pt) |
| MX (1) | MX2019013559A (pt) |
| PL (1) | PL3630092T3 (pt) |
| PT (1) | PT3630092T (pt) |
| RS (1) | RS63347B1 (pt) |
| SI (1) | SI3630092T1 (pt) |
| WO (1) | WO2018219862A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700058311A1 (it) * | 2017-05-29 | 2018-11-29 | Bio Lo Ga Srl | Formulazione a base di vitamina E o di un suo estere per il trattamento di biofilm batterici e fungini |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3755558A (en) * | 1971-02-23 | 1973-08-28 | Du Pont | Polylactide drug mixtures for topical application atelet aggregation |
| JPH09169643A (ja) * | 1995-12-22 | 1997-06-30 | Sekisui Chem Co Ltd | 寄生性皮膚疾患治療用外用剤 |
| IT1302275B1 (it) * | 1998-09-25 | 2000-09-05 | Giorgio Panin | Formulazione di gel idrofobo a base di vitamina e acetato perapplicazione topica. |
| ES2713349T3 (es) * | 2009-04-15 | 2019-05-21 | Bmg Pharma S P A | Composiciones de sal mineral-ácido sulfónico y procedimientos de uso |
| ITUB20153889A1 (it) * | 2015-09-25 | 2017-03-25 | Bio Lo Ga Srl | Gel idrofobico a base di vitamina E esente da prodotti siliconici per applicazione topica |
| ITUB20169882A1 (it) * | 2016-01-08 | 2017-07-08 | Flame S R L | Vitamina E per l’uso nel trattamento e nella prevenzione delle infezioni da biofilm. |
| IT201700058311A1 (it) * | 2017-05-29 | 2018-11-29 | Bio Lo Ga Srl | Formulazione a base di vitamina E o di un suo estere per il trattamento di biofilm batterici e fungini |
-
2017
- 2017-05-29 IT IT102017000058311A patent/IT201700058311A1/it unknown
-
2018
- 2018-05-28 DK DK18727014.5T patent/DK3630092T3/da active
- 2018-05-28 CN CN201880027971.1A patent/CN110650737A/zh active Pending
- 2018-05-28 LT LTEPPCT/EP2018/063926T patent/LT3630092T/lt unknown
- 2018-05-28 BR BR112019023962A patent/BR112019023962A8/pt unknown
- 2018-05-28 HU HUE18727014A patent/HUE059185T2/hu unknown
- 2018-05-28 AU AU2018275487A patent/AU2018275487B2/en active Active
- 2018-05-28 EA EA201992190A patent/EA201992190A1/ru unknown
- 2018-05-28 MX MX2019013559A patent/MX2019013559A/es unknown
- 2018-05-28 ES ES18727014T patent/ES2919423T3/es active Active
- 2018-05-28 GE GEAP201815201A patent/GEP20207179B/en unknown
- 2018-05-28 CA CA3061568A patent/CA3061568C/en active Active
- 2018-05-28 US US16/613,526 patent/US20200360339A1/en not_active Abandoned
- 2018-05-28 SI SI201830680T patent/SI3630092T1/sl unknown
- 2018-05-28 MA MA48936A patent/MA48936B1/fr unknown
- 2018-05-28 EP EP18727014.5A patent/EP3630092B1/en active Active
- 2018-05-28 PL PL18727014.5T patent/PL3630092T3/pl unknown
- 2018-05-28 HR HRP20220808TT patent/HRP20220808T1/hr unknown
- 2018-05-28 RS RS20220631A patent/RS63347B1/sr unknown
- 2018-05-28 PT PT187270145T patent/PT3630092T/pt unknown
- 2018-05-28 WO PCT/EP2018/063926 patent/WO2018219862A1/en active Application Filing
-
2019
- 2019-11-13 CL CL2019003254A patent/CL2019003254A1/es unknown
- 2019-11-14 US US16/683,684 patent/US11234958B2/en active Active
-
2021
- 2021-04-15 US US17/231,761 patent/US20210228541A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MA48936B1 (fr) | 2022-08-31 |
| ES2919423T3 (es) | 2022-07-26 |
| IT201700058311A1 (it) | 2018-11-29 |
| EP3630092B1 (en) | 2022-04-13 |
| MX2019013559A (es) | 2022-02-03 |
| WO2018219862A1 (en) | 2018-12-06 |
| CN110650737A (zh) | 2020-01-03 |
| GEAP201815201A (pt) | 2020-07-27 |
| US11234958B2 (en) | 2022-02-01 |
| CA3061568C (en) | 2024-02-13 |
| US20200360339A1 (en) | 2020-11-19 |
| BR112019023962A2 (pt) | 2020-06-09 |
| AU2018275487A1 (en) | 2019-11-07 |
| LT3630092T (lt) | 2022-06-27 |
| GEP20207179B (en) | 2020-11-10 |
| CL2019003254A1 (es) | 2020-07-03 |
| CA3061568A1 (en) | 2018-12-06 |
| US20210228541A1 (en) | 2021-07-29 |
| SI3630092T1 (sl) | 2022-08-31 |
| PL3630092T3 (pl) | 2022-09-12 |
| DK3630092T3 (da) | 2022-06-20 |
| HUE059185T2 (hu) | 2022-10-28 |
| EA201992190A1 (ru) | 2020-09-03 |
| HRP20220808T1 (hr) | 2022-09-30 |
| US20200121638A1 (en) | 2020-04-23 |
| EP3630092A1 (en) | 2020-04-08 |
| AU2018275487B2 (en) | 2024-03-14 |
| MA48936A (fr) | 2020-04-08 |
| PT3630092T (pt) | 2022-06-02 |
| RS63347B1 (sr) | 2022-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2020014009A2 (es) | Inhibidores de mcl-1 | |
| CL2021000382A1 (es) | Compuestos novedosos de sulfonamidaurea | |
| BR112021006392A2 (pt) | moduladores da alfa-1 antitripsina | |
| BR112015004968A2 (pt) | combinações de compostos ativos | |
| BR112012007521A2 (pt) | concentrados microbicidas estáveis em armazenamento e uso dos mesmos como preservantes | |
| BR112015020302A2 (pt) | derivado de pirazol | |
| BR112016028845A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| UY33885A (es) | Inhibición de la il17 y del ifn-gamma para el tratamiento de las inflamaciones autoinmunes | |
| BR112016021034A8 (pt) | composição farmacêutica, uso da mesma e kit | |
| BR112015030399B8 (pt) | Derivados heterocíclicos, uso dos referidos derivados e composição farmacêutica para a prevenção ou tratamento de doenças associadas com a ativação da proteína stat3 | |
| CY1122289T1 (el) | Φαρμακευτικη συνθεση για χρηση στην αυξηση του τροφισμου της ρινικης βλεννογονου | |
| BR112017022158A2 (pt) | compostos, composições farmacêuticas e uso de um composto | |
| BR112017006425A2 (pt) | derivado de isoxazol como inibidor de isocitrato desidrogenase 1 mutante | |
| CO2022000270A2 (es) | Inhibidores de enzimas | |
| BR112015020222A2 (pt) | compostos de azetidiniloxifenilpirrolidina | |
| CL2008001990A1 (es) | Compuestos derivados de amino-quinazolinas sustituidas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de alzheimer. | |
| BR112017015744A2 (pt) | composto apresentando uma estrutura de fórmula (i), um sal farmaceuticamente aceitável do mesmo ou um isômero ótico do mesmo, composição farmacêutica e uso do composto de fórmula (i) para o tratamento e prevenção de mycobacterium tuberculosis ou outras infecções microbianas | |
| CO2022008690A2 (es) | Compuestos heterocíclicos como inhibidores de delta-5 desaturasa y métodos de uso | |
| BR112019023962A8 (pt) | Formulação à base de vitamina e ou um éster da mesma para tratamento de biofilmes bacterianos e fúngicos | |
| BR102019017062A8 (pt) | Composições tópicas compreendendo pichia anomala e retinol | |
| CL2019001618A1 (es) | Uso de compuestos de carbamato para prevención, alivio o tratamiento del trastorno bipolar. | |
| CR20190391A (es) | Derivados de pirazol como inhibidores de bromodominio | |
| BR112022012368A2 (pt) | Composto, e, composição farmacêutica para o tratamento de doenças associadas a diacilglicerol aciltransferase 2 | |
| BR112012022073A2 (pt) | uso de meloxicam para o tratamento de longa duração de distúrbios musculoesqueletais em gatos. | |
| CO2017001076A2 (es) | Composiciones farmacéuticas antihiperalgésicas, antialodínicas y antiinflamatorias que contienen pregabalina y meloxicam |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B25A | Requested transfer of rights approved |
Owner name: HULKA S.R.L. (IT) |